Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal ...

In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...

Altria Group, Inc. (MO), headquartered in Richmond, Virginia, is a leading producer and seller of smokeable and oral tobacco ...

Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible ...

brand E-vapor products under the NJOY ACE brand It is also one of the world’s largest producers and marketers of medical products in the treatment of illnesses caused by tobacco. Altria sells ...

Altria Group, founded in 1822, manufactures and sells cigarettes, smokeless tobacco products, and alcoholic beverages in the United States and abroad. Its wholly owned subsidiaries include Philip ...

The U.S. Food and Drug Administration has issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco ...